These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3388698)

  • 1. [Natural killer activity and sensitization of the lymphocytes to tissue antigens in lung cancer].
    Red'ko AA; Malygin AM; Dvaladze NA; Pleskach VA; Kutushev FKh
    Vestn Khir Im I I Grek; 1988 Feb; 140(2):12-5. PubMed ID: 3388698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
    Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
    Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune reactivity to Thomsen-Friedenreich antigen in patients with lung cancer detected by superoxide assay-leukocyte adherence inhibition test.
    Ichinose Y; Yagawa K; Kaku M; Hara N; Ohta M
    Cancer Res; 1985 Sep; 45(9):4473-7. PubMed ID: 2992780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and inhibitory activity of regional lymph node cells on the cytotoxicity of autologous killer cells in patients with primary lung cancer].
    Kadoyama C; Kimura H; Yamaguchi Y
    Gan To Kagaku Ryoho; 1987 Oct; 14(10):2906-11. PubMed ID: 2959205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beneficial effects of interleukin-2 on natural killer activity in lung cancer patients.
    Ito M; Suzuki H; Yamashita N; Sugiyama E; Maruyama M; Sato M; Iwata M; Yano S
    Anticancer Res; 1984; 4(6):375-8. PubMed ID: 6097158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer.
    Esendagli G; Bruderek K; Goldmann T; Busche A; Branscheid D; Vollmer E; Brandau S
    Lung Cancer; 2008 Jan; 59(1):32-40. PubMed ID: 17825949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The response of peripheral blood lymphocytes from lung cancer patients to in-vitro treatment with recombinant interleukin-2].
    Pogodina ON; Karaseva NA; Ivanov VA
    Tsitologiia; 1997; 39(7):582-9. PubMed ID: 9490499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of lymphokine-activated killer activities in peripheral blood lymphocytes and regional lymph node lymphocytes against PC-9 cultured adenocarcinoma and autologous pulmonary adenocarcinoma cells.
    Morikawa Y; Watanabe S; Kodama T
    Jpn J Clin Oncol; 1987 Jun; 17(2):129-39. PubMed ID: 3497285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-12-mediated killer activity in lung cancer patients.
    Haku T; Yanagawa H; Nabioullin R; Takeuchi E; Sone S
    Cytokine; 1997 Nov; 9(11):846-52. PubMed ID: 9367545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of tumor status on the regulation of natural killer cell activity by tumor-associated fetal antigens.
    Hogan KT; Harris DT; Plunkett SR; Raben M; Hale AH; Evans DL
    J Biol Response Mod; 1985 Aug; 4(4):353-7. PubMed ID: 3839842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of tumor antigens on leukocyte adherence in the blood in stomach cancer].
    Zharkov VV; Novikov DK
    Vopr Onkol; 1983; 29(2):14-8. PubMed ID: 6836968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of sera of breast cancer patients on NK cell activity].
    Konjević G; Spuzić I
    Srp Arh Celok Lek; 1995; 123(9-10):227-31. PubMed ID: 17974436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The count of the large granule-containing lymphocytes of the peripheral blood and the natural killer activity in patients with malignant tumors].
    Kindzel'skiĭ LP; Zlochevskaia LL; Tsyganok TV; Shabaeva MM; Zhukova MM; Rudaia OI
    Vrach Delo; 1990 Aug; (8):31-2. PubMed ID: 2256279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity tests against cultured human lung cancer cells with autologous lymphocytes activated in vitro by mitomycin C-treated tumor monolayers in the presence of T-cell growth factor.
    Kimura H; Yamaguchi Y; Kadoyama C; Sato N; Fujisawa T
    Jpn J Clin Oncol; 1983 Mar; 13(1):3-13. PubMed ID: 6300483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
    Ludwig HJ; Storch H
    Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral leukocyte adherence inhibition (H-LAI) test in screening of high risk group for lung cancer.
    Kubasova T; Bank J; Köteles GJ; Horváth M
    Neoplasma; 1990; 37(2):173-8. PubMed ID: 2188164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Determination of antigen-dependent activity of human lung cancer transfer factor by H3-leucine leucine leukocyte adherence inhibition assay].
    Xu WM
    Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):116-8. PubMed ID: 1377621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
    Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of colon and lung cancer patients with ex vivo heat shock protein 70-peptide-activated, autologous natural killer cells: a clinical phase i trial.
    Krause SW; Gastpar R; Andreesen R; Gross C; Ullrich H; Thonigs G; Pfister K; Multhoff G
    Clin Cancer Res; 2004 Jun; 10(11):3699-707. PubMed ID: 15173076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.